CereGate
3 known investors
Find your way into CereGate
353 people in our graph share verified history with the CereGate team — schools, employers, funds. One of them is your warm intro.
Toby Obstbaumunlockedknows Matthias Puls · together at USI Università della Svizzera italiana (overlapped)
×6knows the team · via Trinity College Dublin
×4knows the team · via University of Saskatchewan
knows the team · via Johannes Kepler Universität Linz
Ceregate develops brain-computer interface and neuromodulation technologies to improve patient outcomes in neurodisorders. The company brings together expertise in neuroscience, engineering, and medical devices to advance non-invasive neuromodulation solutions.
Founders & leadership
MP
Matthias PulsinCEOHe brings 17 years of healthcare and medtech experience, including prior roles leading digital therapeutics at Gerresheimer and as co-founder and CEO of Kenkou (acquired by BIOTRONIK), alongside advisory and teaching work in digital health innovation.
BB
Brian BlischakinPresidentHe has spent his career in medical device commercialization, leading teams through the development and market launch of multiple implantable neurological devices including deep brain stimulators and nerve stimulators across clinical development, reimbursement, and international markets.
Investors · 3
Funding
SEC filings, press & company announcements- Undisclosed amountseries ASep 2020
Heal Capital (lead), High-Tech Gründerfonds (HTGF), TruVenturo
Source ↗
Source: company announcements and press reports — follow each round's link for the claim.
In the news
Frequently asked questions
- What does CereGate do?
- Ceregate develops brain-computer interface and neuromodulation technologies to improve patient outcomes in neurodisorders. The company brings together expertise in neuroscience, engineering, and medical devices to advance non-invasive neuromodulation solutions.
- Who are CereGate's investors?
- CereGate's investors include Heal Capital, TruVenturo GmbH, 468 Capital.